文献速递神经肿瘤

胶质瘤患者疾病全程的症状患病率:一项系统综述

Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review.
PubMed 文献 · J Neurooncol · 2018-10-30

该系统综述检索MEDLINE、CINAHL和EMBASE,纳入32篇论文,识别出25种症状,计算各症状患病率的加权均值。最常见的十种症状为癫痫发作(37%)、认知缺陷(36%)、嗜睡(35%)、吞咽困难(30%)、头痛(27%)、意识模糊(27%)、失语(24%)、运动缺陷(21%)、疲劳(20%)和呼吸困难(20%)。作者认为十种最常见症状中有八种与中枢神经系统相关,因此为胶质瘤特异性症状,并强调量身定制症状护理的重要性。

要点

  • 胶质瘤患者最常见的症状为癫痫发作(37%)、认知缺陷(36%)和嗜睡(35%)。
  • 十种最常见症状中有八种与中枢神经系统相关,为胶质瘤特异性症状。
  • 研究结果可能有助于开发针对不同疾病阶段的胶质瘤特异性患者报告结局测量工具(PROM)。

核心结论

  • 胶质瘤患者十种最常见症状中有八种与中枢神经系统相关,因此为胶质瘤特异性症状。
  • 研究结果强调为胶质瘤患者量身定制症状护理的重要性,并可能有助于开发针对不同疾病阶段的胶质瘤特异性PROM。

研究设计与样本

  • 系统综述,按照PRISMA建议在MEDLINE、CINAHL和EMBASE中检索,聚焦胶质瘤患者在不同疾病和治疗阶段的症状患病率。
  • 共识别出25种症状,并计算各症状患病率的加权均值。

主要发现

  • 十种最常见症状为:癫痫发作(37%)、认知缺陷(36%)、嗜睡(35%)、吞咽困难(30%)、头痛(27%)、意识模糊(27%)、失语(24%)、运动缺陷(21%)、疲劳(20%)和呼吸困难(20%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Glioma patients suffer from a wide range of symptoms which influence quality of life negatively. The aim of this review is to give an overview of symptoms most prevalent in glioma patients throughout the total disease trajectory, to be used as a basis for the development of a specific glioma Patient Reported Outcome Measure (PROM) for early assessment and monitoring of symptoms in glioma patients. METHODS: A systematic review focused on symptom prevalence in glioma patients in different phases of disease and treatment was performed in MEDLINE, CINAHL and EMBASE according to PRISMA recommendations. We calculated weighted means for prevalence rates per symptom. RESULTS: The search identified 2.074 unique papers, of which 32 were included in this review. In total 25 symptoms were identified. The ten most prevalent symptoms were: seizures (37%), cognitive deficits (36%), drowsiness (35%), dysphagia (30%), headache (27%), confusion (27%), aphasia (24%), motor deficits (21%), fatigue (20%) and dyspnea (20%). CONCLUSIONS: Eight out of ten of the most prevalent symptoms in glioma patients are related to the central nervous system and therefore specific for glioma. Our findings emphasize the importance of tailored symptom care for glioma patients and may aid in the development of specific PROMs for glioma patients in different phases of the disease.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. IJzerman-Korevaar M, Snijders TJ, de Graeff A, et al. Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review. J Neurooncol. 2018. PMID: 30377935. doi:10.1007/s11060-018-03015-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。